Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | peptidase, M28 family protein | 0.0058 | 0.0391 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0051 | 0.0175 | 0.0175 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0051 | 0.0175 | 0.0175 |
Echinococcus multilocularis | n acetylated alpha linked acidic dipeptidase 2 | 0.0058 | 0.0391 | 0.0391 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0051 | 0.0175 | 0.0175 |
Mycobacterium ulcerans | lipoprotein aminopeptidase LpqL | 0.0058 | 0.0391 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0161 | 0.3636 | 0.3636 |
Echinococcus granulosus | GPCR family 2 | 0.0051 | 0.0175 | 0.0175 |
Schistosoma mansoni | hypothetical protein | 0.011 | 0.2034 | 0.2034 |
Loa Loa (eye worm) | leucyl aminopeptidase | 0.0058 | 0.0391 | 0.0391 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0058 | 0.0391 | 0.5 |
Echinococcus multilocularis | endoplasmic reticulum metallopeptidase 1 | 0.0058 | 0.0391 | 0.0391 |
Brugia malayi | FXNA | 0.0058 | 0.0391 | 0.0391 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0051 | 0.0175 | 0.0175 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.005 | 0.0147 | 0.0147 |
Trypanosoma cruzi | glutaminyl cyclase, putative | 0.0058 | 0.0391 | 1 |
Schistosoma mansoni | glutaminyl cyclase (M28 family) | 0.0364 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0058 | 0.0391 | 1 |
Mycobacterium tuberculosis | Probable lipoprotein aminopeptidase LpqL | 0.0058 | 0.0391 | 0.5 |
Schistosoma mansoni | NAALADASE L peptidase (M28 family) | 0.0058 | 0.0391 | 0.0391 |
Schistosoma mansoni | glutaminyl-peptide cyclotransferase-related | 0.0058 | 0.0391 | 0.0391 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0051 | 0.0175 | 0.0175 |
Echinococcus multilocularis | glutaminyl peptide cyclotransferase | 0.0364 | 1 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.005 | 0.0147 | 0.0147 |
Brugia malayi | nicalin | 0.0058 | 0.0391 | 0.0391 |
Schistosoma mansoni | hypothetical protein | 0.0051 | 0.0175 | 0.0175 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0161 | 0.3636 | 0.3636 |
Trichomonas vaginalis | Clan MH, family M28, aminopeptidase S-like metallopeptidase | 0.0058 | 0.0391 | 0.5 |
Echinococcus granulosus | endoplasmic reticulum metallopeptidase 1 | 0.0058 | 0.0391 | 0.0391 |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.0391 | 0.0391 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0161 | 0.3636 | 0.3636 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0051 | 0.0175 | 0.0175 |
Onchocerca volvulus | Glutaminyl cyclase homolog | 0.0364 | 1 | 1 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.005 | 0.0147 | 0.0147 |
Echinococcus granulosus | glutaminyl peptide cyclotransferase | 0.0364 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.011 | 0.2034 | 0.2034 |
Brugia malayi | leucyl aminopeptidase | 0.0058 | 0.0391 | 0.0391 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.005 | 0.0147 | 0.0147 |
Toxoplasma gondii | hypothetical protein | 0.0058 | 0.0391 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0058 | 0.0391 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.0391 | 0.0391 |
Mycobacterium tuberculosis | Conserved protein | 0.0058 | 0.0391 | 0.5 |
Echinococcus multilocularis | GPCR, family 2 | 0.0051 | 0.0175 | 0.0175 |
Schistosoma mansoni | nicalin (M28 family) | 0.0058 | 0.0391 | 0.0391 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0051 | 0.0175 | 0.0175 |
Leishmania major | glutaminyl cyclase, putative | 0.0058 | 0.0391 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0364 | 1 | 1 |
Trypanosoma brucei | glutaminyl cyclase, putative | 0.0058 | 0.0391 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.005 | 0.0147 | 0.0147 |
Schistosoma mansoni | hypothetical protein | 0.0051 | 0.0175 | 0.0175 |
Mycobacterium ulcerans | hypothetical protein | 0.0058 | 0.0391 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.0391 | 0.0391 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0058 | 0.0391 | 0.5 |
Schistosoma mansoni | Fxna peptidase (M28 family) | 0.0058 | 0.0391 | 0.0391 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.005 | 0.0147 | 0.0147 |
Echinococcus multilocularis | endoplasmic reticulum metallopeptidase 1 | 0.0058 | 0.0391 | 0.0391 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.011 | 0.2034 | 0.2034 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0051 | 0.0175 | 0.0175 |
Loa Loa (eye worm) | hypothetical protein | 0.0051 | 0.0175 | 0.0175 |
Echinococcus granulosus | endoplasmic reticulum metallopeptidase 1 | 0.0058 | 0.0391 | 0.0391 |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.0391 | 0.0391 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.005 | 0.0147 | 0.0147 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.005 | 0.0147 | 0.0147 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.005 | 0.0147 | 0.0147 |
Schistosoma mansoni | hypothetical protein | 0.0051 | 0.0175 | 0.0175 |
Trypanosoma cruzi | glutaminyl cyclase, putative | 0.0058 | 0.0391 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0161 | 0.3636 | 0.3636 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.